Article Information
History
- May 1, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marc Souris1,*,
- Léon Tshilolo2,3,
- Daniel Parzy4,
- Rachel Kamgaing5,
- Destin Mbongi3,
- Baltazar Phoba3,
- Marie-Anasthasie Tshilolo3,
- René Mbungu3,
- Pierre Morand6 and
- Jean-Paul Gonzalez7
- 1UMR Unité des Virus Émergents (UVE Aix-Marseille Univ-IRD 190-Inserm 1207), Marseille 13005 France
- 2Centre Hospitalier Mère-Enfant Monkole, Kinshasa, RD Congo
- 3Centre de Formation et d’Appui Sanitaire (CEFA), Mont-Ngafula, Kinshasa. BP 817 - RD Congo
- 4Defideva/Altadeva – Biological Lab, Luminy Biotech, Marseille 13009 France
- 5Centre International de Reference Chantal Biya (CIRCB), Yaoundé, Cameroon
- 6UMI « Résiliences » (IRD-CIRES), Bondy 93143 France
- 7School of Medicine, Georgetown University, Department of Microbiology & Immunology, Washington, DC 20057 USA. Centaurus Biotech LLC, Vienna, VA, USA
- ↵*Corresponding author
Marc SOURIS, marc.souris{at}ird.fr
Posted May 01, 2021.
Pre-pandemic SARS-CoV-2 potential natural immunity among population of the Democratic Republic of Congo
